Quick stool test device could cut isolation time for cancer patients

NCT ID NCT06495775

Completed Knowledge-focused Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study tested a new device for collecting stool samples right at the bedside in 50 cancer patients admitted with diarrhea. The goal was to see if the device could get samples faster than usual methods, helping doctors diagnose infections sooner and reduce how long patients need to stay in isolation. The device was also checked for safety to ensure it caused no harm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fecal sampling device
What this could lead to: If successful, this device could help doctors get stool samples faster from patients with diarrhea, leading to quicker diagnosis and less time in isolation.
What could go wrong: This is a small feasibility study with only 50 patients, so results may not apply to all hospital settings. The device's real-world impact on treatment speed is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEASIBILITY STUDY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FEASIBILITY STUDY

Contacts and locations

Locations

Zealand University Hospital

Roskilde, Region Sjælland, 4000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.